In March 2025, the company introduced new designs to get a immediate-to-customer featuring of its Wegovy weight loss drug. The company recognized a fresh pharmacy, known as NovoCare, which would demand buyers $499 per month for usage of the drug, less than half the cost of the drug through other pharmaceutical distribution networks.[fifty three]Inc